Update on Combination Strategies of PARP Inhibitors
The application of PARP inhibitors has revolutionized cancer treatment and has achieved significant advancements, particularly with regard to tumors with defects in genes involved in homologous recombination repair (HRR) processes, such as BRCA1 and BRCA2. Despite the promising outcomes of PARP inhi...
Saved in:
| Main Authors: | Zhuoqun Lin, Lingfang Wang PhD, Ziyu Xing, Fenfen Wang MD, Xiaodong Cheng MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748241298329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic review
by: Ying-Wen Wang, et al.
Published: (2025-03-01) -
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's Sarcoma.
by: Sonja J Gill, et al.
Published: (2015-01-01) -
A Nomogram for Predicting Cancer-Specific Survival in Patients With Stage I Vulvar Squamous Cell Carcinoma: A Study Based on the SEER Database and External Validation
by: Yingfan Zhu MD, et al.
Published: (2025-06-01) -
Clinical approaches to overcome PARP inhibitor resistance
by: Yutian Zou, et al.
Published: (2025-05-01) -
Multi-analyte approach combining cfDNA sequencing and protein testing for early ovarian cancer detection
by: Fenfen Wang, et al.
Published: (2025-06-01)